Category: prices

Here’s Why Piper Sandler Considers DRAM Pricing ‘Slightly Negative’ for Micron and Others

Piper Sandler analysts Weston Twigg and Harsh Kumar jointly noted that inSpectrum released its January monthly memory contract pricing data, which indicated DRAM 8Gb DDR4 fell 8 percent month-over-month and that NAND 256Gb TLC dropped 1 percent on a month-over-month basis. The analysts, who monitor the three-month rolling average year-over-year change to better gauge trends, said DRAM products’…


UK House Prices Rise at Fastest Rate Since 2007: Halifax

LONDON—British house prices in December were 9.8 percent higher than a year earlier, the sharpest annual increase since the eve of the global financial crisis in July 2007, monthly figures from mortgage lender Halifax showed on Friday. House prices rose by 1.1 percent in December alone, the same increase as in November, and recorded their…


Oil Prices Ease, Focus Shifts to Next OPEC+ Move

LONDON—Brent crude futures snapped a three-day rally on Friday in light trading before the Christmas holidays but the benchmark was still headed for a weekly gain, with the market focusing on next steps by OPEC+ and the impact of the Omicron variant. Brent crude futures fell 75 cents, or 1 percent, to $76.10 a barrel…


Oil Prices Extend Rise on Reduced Fears of Omicron-Induced Demand Slump

NEW YORK—Oil prices bounced in a light-volume session on Thursday, on signs that the worst effects of the Omicron variant might be more containable than previously feared, even as countries imposed travel restrictions on surging infection levels. The oil market has wavered in recent days over how seriously to take the threat of another slump…


Champagne Shortage Likely to Push Up Prices of Bubbly Over Holidays

With New Year’s Eve a little over a week away, experts say revelers should brace for higher prices of champagne and difficulty finding the most popular brands amid a global shortage of bubbly. The COVID-19 pandemic has impacted supply chains in various ways, with champagne being the latest casualty. “There actually is a shortage of…


Holiday Treats Expected to Cost More During Supply Chain Crisis

Plenty of chestnuts will be available for roasting on an open fire this season, but supply chain slowdowns are expected to affect the cost and availability of many other holiday treats across the country during the holidays. Making “George Washington’s Eggnog,” a popular online recipe, could be a pricey treat this year. The recipe calls…


Oil Prices Steady as Omicron Caution Lingers

LONDON—Oil prices were steady on Wednesday as fears of tight supply were offset by COVID-19 concerns after Singapore suspended quarantine-free travel and Australia renewed its vaccination push due to a surge in Omicron variant cases. U.S. West Texas Intermediate (WTI) crude futures were unchanged at $71.12 a barrel at 1250 GMT after jumping 3.7 percent…


Amazon Dominates Holiday Price War, Causes Retail Ripple Effect

The holiday shopping season is in full swing, although many customers are finding higher prices on products in the market. They are also witnessing an ongoing price war between various retail giants. According to the data analytics company Profitero, Amazon.com, Inc. is the first retail firm to increase its prices. Profitero tracks almost 20,000 popular…


The Week Ahead in Biotech (Nov. 28 – Dec. 4): FDA Decisions for VBI Vaccines, BeyondSpring, CTI Biopharma and Merck Take the Spotlight in a Light Calendar Week

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week. Shares of companies with a COVID portfolio, including a vaccine, a treatment, or both, reacted with strong moves to the…


The Week Ahead in Biotech (Nov. 28 – Dec. 4)

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week. Shares of companies with a COVID portfolio, including a vaccine, a treatment, or both, reacted with strong moves to the…